AA clinical trial for adolescent age 6-18, evaluating the safety and efficacy of Baricitinib.

AA clinical trial for adolescent age 6-18, evaluating the safety and efficacy of Baricitinib.

Veracity Clinical Research – a Dermatology Clinical Trial Site in Brisbane is currently hosting alopecia clinical trials.

This is for all forms of Alopecia Areata (including Totalis and Universalis)

There is one study currently recruiting: JAIO Clinical Trial of Baricitinib for Alopecia in 6-18yo
(https://clinicaltrials.gov/study/NCT05723198?cond=Alopecia%20Areata&term=JAIO&rank=1)

As well as another study due to start recruiting in 1-2 months: M23-716: Clinical Trial of Upadacitinib for Alopecia in adolescents (>12) and adults.
(https://clinicaltrials.gov/study/NCT06012240?cond=Alopecia%20Areata&term=M23-716&rank=1)

To participate or learn more please contact one of the sites below hosting trials:

Skin and Cancer Foundation Australia – Darlinghurst Clinic
Contact: 8651 2027
Principal Investigator: Johanna Kuchel

Royal North Shore Hospital St Leonards,
Contact: 0299660625 Principal Investigator: Rebecca Saunderson

Veracity Clinical Research, Woolloongabba, QLD
Contact: 07 30391346
Principal Investigator: Lynda Spelman

Sinclair Dermatology, Melbourne, Victoria, Australia, 3002
Contact: 03 9013 0099
Principal Investigator: Samantha Eisman

Institute for Skin, Health, and Immunity Mitcham, Victoria, Australia, 3132
Contact: 0412476267
Principal Investigator: John Su